Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Canadian researchers claim hirudin derivative

Nov. 8, 1996

Factor Xa/thrombin inhibitors from Roche

Nov. 1, 1996

Berlex discloses factor Xa inhibitors

Nov. 1, 1996

Transgenic ATIII proven safe in healthy volunteers

Oct. 25, 1996

Promising preliminary phase II results for argatroban in acute MI

Oct. 25, 1996

Servier selects TxA2 antagonist for further study

Oct. 18, 1996

Antiplatelet agents from Taisho

Oct. 18, 1996

Antithrombotic prostaglandin analogue revealed by Asahi Glass

Oct. 18, 1996

BASF reports on novel thrombin inhibitors

Oct. 18, 1996

Bristol-Myers Squibb to develop Toray antiplatelet agent in the U.S. and Canada

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...